| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 137061-48-4 | 腺苷酸环化酶激活肽-38(抗原) | H-HIS-Ser-ASP-Gly-Ile-PHE-THR-ASP-Ser-TYR-Ser-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-AL; H-HIS-Ser-ASP-Gly-Ile-PHE-THR-ASP-Ser-TYR-Ser-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-Gly-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2; HIS-Ser-ASP-Gly-Ile-PHE-THR-ASP-Ser-TYR-Ser-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-Gly-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2; HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; ADENYLATE CYCLASE ACTIVATING PEPTIDE-38; ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38; PACAP (1-38), AMIDE, HUMAN, OVINE, RAT; PACAP (1-38), HUMAN, OVINE, RAT; PACAP (1-38) (HUMAN, SHEEP, RAT) | 无 | C203H331N63O53S1 | 详情 | 供应商 |
| 118068-30-7 | Ser-ASN-ASN-PHE-Gly-ALA-Ile-LEU-Ser-Ser | H-Ser-ASN-ASN-PHE-Gly-ALA-Ile-LEU-Ser-Ser-OH; H-Ser-ASN-ASN-PHE-Gly-ALA-Ile-LEU-Ser-Ser-OH; AMYLIN FRAGMENT 20-29 HUMAN; AMYLIN (20-29); AMYLIN (20-29) (HUMAN); SNNFGAILSS; Ser-ASN-ASN-PHE-Gly-ALA-Ile-LEU-Ser-Ser; diabetes associated peptide fragment 20-29 human | ![]() | C43H68N12O16 | 详情 | 供应商 |
| 90984-99-9 | ARG-ARG-Ser-Ser-CYS-PHE-Gly-Gly-ARG-Ile-ASP-ARG-Ile-Gly-ALA-GLN-Ser-Gly-LEU-Gly-CYS-ASN-Ser-PHE-ARG- | ARG-ARG-Ser-Ser-CYS-PHE-Gly-Gly-ARG-Ile-ASP-ARG-Ile-Gly-ALA-GLN-Ser-Gly-LEU-Gly-CYS-ASN-Ser-PHE-ARG-; H-ARG-ARG-Ser-Ser-CYS-PHE-Gly-Gly-ARG-Ile-ASP-ARG-Ile-Gly-ALA-GLN-Ser-Gly-LEU-Gly-CYS-ASN-Ser-PHE-ARG-TYR-OH; ATRIAL NATRIURETIC PEPTIDE RAT FRAGMENT 3-28; ATRIAL NATRIURETIC FACTOR (3-28) (RAT); ATRIAL NATRIURETIC PEPTIDE (3-28), RAT; A-TYPE (ATRIAL) NATRIURETIC PEPTIDE (RAT, 3-28); ARG-ARG-Ser-Ser-CYS-PHE-Gly-Gly-ARG-Ile-ASP-ARG-Ile-Gly-ALA-GLN-Ser-Gly-LEU-Gly-CYS-ASN-Ser-PHE-ARG-TYR; ANP (RAT, 3-28); ANP (3-28), RAT | ![]() | C119H189N43O36S2 | 详情 | 供应商 |
| 113873-67-9 | 神经储钙蛋白基质 | ASP-LEU-ASP-VAL-PRO-Ile-PRO-Gly-ARG-PHE-ASP-ARG-ARG-VAL-Ser-VAL-ALA-ALA-GLU; ASP-LEU-ASP-VAL-PRO-Ile-PRO-Gly-ARG-PHE-ASP-ARG-ARG-VAL-Ser-VAL-ALA-ALA-GLU; DLDVPIPGRFDRRVSVAAE; CALCINEURIN (PP2B) SUBSTRATE [DLDVPIPGRFDRRVSSVAAE], NON-PHOSPHORYLATED; CALCINEURIN SUBSTRATE; H-ASP-LEU-ASP-VAL-PRO-Ile-PRO-Gly-ARG-PHE-ASP-ARG-ARG-VAL-Ser-VAL-ALA-ALA-GLU-OH; [ALA-97]-RII (81-99); Calcineurin (PP2B) Substrate [DLDVPIPGRFDRRVSVAAE], Non-Phosphorylated | ![]() | C92H150N28O29 | 详情 | 供应商 |
| 245329-01-5 | PAR-2 (6-1) AMIDE (MOUSE, RAT) | LRGILSAMIDE; H-LEU-ARG-Gly-Ile-LEU-Ser-NH2; LRGILSAMIDE; PAR-2 (6-1) AMIDE (MOUSE, RAT); LRGILS-NH2 | ![]() | C29H56N10O7 | 详情 | 供应商 |
| 83139-29-1 | PTH (1-34) AMIDE (HUMAN) | H-Ser-VAL-Ser-GLU-Ile-GLN-LEU-MET-HIS-ASN-LEU-Gly-LYS-HIS-LEU-ASN-Ser-MET-GLU-ARG-VAL-GLU-TRP-LEU-AR; H-Ser-VAL-Ser-GLU-Ile-GLN-LEU-MET-HIS-ASN-LEU-Gly-LYS-HIS-LEU-ASN-Ser-MET-GLU-ARG-VAL-GLU-TRP-LEU-ARG-LYS-LYS-LEU-GLN-ASP-VAL-HIS-ASN-PHE-NH2; PTH (1-34) AMIDE (HUMAN); 1-34-Human pth amide; 1-34-Human pth-nh2; Hpth-(1-34)-nh2; Human parathyroid hormone (1-34) amide; L-Phenylalaninamide, L-Seryl-L-valyl-L-Seryl-L-alpha-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylGlycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-Seryl-L-methionyl-L-alpha-glutamyl-L-arginyl-L-valyl-L-alpha-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-valyl-L-histidyl-L-asparaginyl- | 无 | C181H292N56O50S2 | 详情 | 供应商 |
| 122613-29-0 | LEU-LEU-TYR-GLU-MET-LEU-ALA-Gly-GLN-ALA-PRO-PHE-GLU-Gly-GLU-ASP-GLU-ASP-GLU-LEU-PHE-GLN-Ser-Ile-MET- | H-LEU-LEU-TYR-GLU-MET-LEU-ALA-Gly-GLN-ALA-PRO-PHE-GLU-Gly-GLU-ASP-GLU-ASP-GLU-LEU-PHE-GLN-Ser-Ile-ME; PKC (530-558); PKC FRAGMENT (530-558); PROTEIN KINASE C (530-558); PROTEIN KINASE C FRAGMENT 530-558; LLYEMLAGQAPFEGEDEDELFQSIMEHNV; LLYEMLAGQAPFEGEDEDELFQSIMEHNV-NH2; H-LEU-LEU-TYR-GLU-MET-LEU-ALA-Gly-GLN-ALA-PRO-PHE-GLU-Gly-GLU-ASP-GLU-ASP-GLU-LEU-PHE-GLN-Ser-Ile-MET-GLU-HIS-ASN-VAL-NH2; H-LEU-LEU-TYR-GLU-MET-LEU-ALA-Gly-GLN-ALA-PRO-PHE-GLU-Gly-GLU-ASP-GLU-ASP-GLU-LEU-PHE-GLN-Ser-Ile-MET-GLU-HIS-ASN-VAL-NH2 | ![]() | C148H221N35O50S2 | 详情 | 供应商 |
| 112955-31-4 | ALA-VAL-Ser-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-Gly-LYS-Ser-Ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS- | ALA-VAL-Ser-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-Gly-LYS-Ser-Ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-; PTH-RP (HUMAN, 1-34 AMIDE) (RAT, MOUSE); PARATHYROID HORMONE RELATED PROTEIN (HUMAN, 1-34 AMIDE) (RAT, MOUSE); ALA-VAL-Ser-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-Gly-LYS-Ser-Ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA-NH2; HYPERCALCEMIA OF MALIGNANCY FACTOR*FRAGM ENT 1-34 AM; ala-val-Ser-glu-his-gln-leu-leu-his-asp-lys-Gly-lys-Ser-Ile-gln-asp-leu-arg-arg-arg-phe-phe-leu-his-his-leu-Ile-ala-glu-Ile-his-thr-ala-nh2; Parathyroid hormone-related protein (1-34) Amide, PTHrP (1-34) amide, Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2; Humoral Hypercalcemic Factor (hHCF)(1-34)-NH2 (Human) | 无 | C180H288N58O47 | 详情 | 供应商 |
| 125934-45-4 | GLU-Ile-Gly-ASP-GLU-GLU-ASN-Ser-ALA-LYS-PHE-PRO-Ile-NH2 | H-GLU-Ile-Gly-ASP-GLU-GLU-ASN-Ser-ALA-LYS-PHE-PRO-Ile-NH2; EIGDEENSAKFPI-NH2; H-GLU-Ile-Gly-ASP-GLU-GLU-ASN-Ser-ALA-LYS-PHE-PRO-Ile-NH2; GLU-Ile-Gly-ASP-GLU-GLU-ASN-Ser-ALA-LYS-PHE-PRO-Ile-NH2; NEUROPEPTIDE EI RAT; NEUROPEPTIDE EL (RAT); NEI (RAT); Neuropeptide EI (human, mouse, rat); Neuropeptide EI, NEI, rat | ![]() | C63H98N16O23 | 详情 | 供应商 |
| 144189-71-9 | 淀粉Β-蛋白(22-35); 淀粉Β-蛋白(22-35); H-EDVLGSNKGAIIGLM-OH | H-GLU-ASP-VAL-Gly-Ser-ASN-LYS-Gly-ALA-Ile-Ile-Gly-LEU-MET-OH; AMYLOID BETA-PROTEIN FRAGMENT 22-35; AMYLOID BETA-PROTEIN (22-35); EDVGSNKGAIIGLM; H-GLU-ASP-VAL-Gly-Ser-ASN-LYS-Gly-ALA-Ile-Ile-Gly-LEU-MET-OH; GLU-ASP-VAL-Gly-Ser-ASN-LYS-Gly-ALA-Ile-Ile-Gly-LEU-MET; BETA-AMYLOID (22-35); AMYLOID B-PROTEIN FRAGMENT 22-35; amyloid β-protein fragment 22-35 | ![]() | C59H102N16O21S | 详情 | 供应商 |
| 118691-44-4 | CYS-PHE-Gly-Ser-ARG-Ile-ASP-ARG-Ile-Gly-ALA-GLN-Ser-Gly-MET-Gly-CYS-Gly-ARG-ARG-PHE (DISULFIDE BRIDG | ATRIAL NATRIURETIC PEPTIDE (4-24), FROG; H-CYS-PHE-Gly-Ser-ARG-Ile-ASP-ARG-Ile-Gly-ALA-GLN-Ser-Gly-MET-Gly-CYS-Gly-ARG-ARG-PHE-OH (DISULFIDE BRIDGE: 1-17); FANP-21; CFGSRIDRIGAQSGMGCGRRF (DISULFIDE BRIDGE: 1-17); ATRIAL NATRIURETIC PEPTIDE (4-24), FROG; ATRIAL NATRIURETIC PEPTIDE FROG: FRAGMENT 4-24; anf 4-24; atrial natriuretic peptide fragment 4-24 frog; ANF 4-24, fANP-21 | ![]() | C93H150N34O27S3 | 详情 | 供应商 |
| 99534-03-9 | THR-THR-TYR-ALA-ASP-PHE-Ile-ALA-Ser-Gly-ARG-THR-Gly-ARG-ARG-ASN-ALA-Ile-HIS-ASP; THR-THR-TYR-ALA-ASP- | H-THR-THR-TYR-ALA-ASP-PHE-Ile-ALA-Ser-Gly-ARG-THR-Gly-ARG-ARG-ASN-ALA-Ile-HIS-ASP-OH; H-TTYADFIASGRTGRRNAIHD; H-THR-THR-TYR-ALA-ASP-PHE-Ile-ALA-Ser-Gly-ARG-THR-Gly-ARG-ARG-ASN-ALA-Ile-HIS-ASP-OH; CAMP DEPENDENT PK INHIBITOR (5-24); CAMP-DEPENDENT PROTEIN KINASE INHIBITOR (5-24); CAMP-DEPENDENT PROTEIN KINASE INHIBITOR-ALPHA (5-24) (HUMAN, MOUSE, RABBIT, RAT); ip20; TTYADFIASGRTGRRNAIHD; THR-THR-TYR-ALA-ASP-PHE-Ile-ALA-Ser-Gly-ARG-THR-Gly-ARG-ARG-ASN-ALA-Ile-HIS-ASP | ![]() | C94H148N32O31 | 详情 | 供应商 |
| 92915-79-2 | Ile-Ser-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-Ile-ASN-GLU-ALA-Gly-ARG | H-Ile-Ser-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-Ile-ASN-GLU-ALA-Gly-ARG-OH; OVALBUMIN CHICKEN (323-339); OVALBUMIN (323-339) (CHICKEN, JAPANESE QUAIL); OVA (323-339); OVA (323-339) (CHICKEN, JAPANESE QUAIL); H2N-ISQAVHAAHAEINEAGR-OH; Ile-Ser-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-Ile-ASN-GLU-ALA-Gly-ARG; H-Ile-Ser-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-Ile-ASN-GLU-ALA-Gly-ARG-OH; ISQAVHAAHAEINEAGR | ![]() | C74H120N26O25 | 详情 | 供应商 |
| 102068-15-5 | PGLA | Gly-Met-Ala-Ser-Lys-Ala-Gly-Ala-Ile-Ala-Gly-Lys-Ile-Ala-Lys-Val-Ala-Leu-Lys-Ala-Leu-NH2; peptide-Gly-Leu-amide | ![]() | C88H162N26O22S | 详情 | 供应商 |
| 112540-82-6 | ALA-VAL-Ser-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-Gly-LYS-Ser-Ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA; ALA-VAL-Ser-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-Gly-LYS-Ser-Ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA; ALA-VAL-Ser-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-Gly-LYS-Ser-Ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-VAL-Ser-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-Gly-LYS-Ser-Ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-ALA-VAL-Ser-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-Gly-LYS-Ser-Ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-VAL-Ser-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-Gly-LYS-Ser-Ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 无 | C180H287N57O48 | 详情 | 供应商 |
| 17998-69-5 | H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | 无 | 详情 | 供应商 | ||